Large cell neuroendocrine carcinoma arising from the anterior mediastinum.
Annalisa MontebelloElizier Zahra BiancoDarko BabicNicholas Paul DelicataNeville AzzopardiPublished in: BMJ case reports (2021)
Anterior mediastinal large cell neuroendocrine carcinomas (LCNECs) are extremely rare, extremely aggressive malignancies that carry a dismal prognosis. We discuss a woman aged 60 years who presented with a 2-month history of recurrent severe constant epigastric pain. Abdominal examination revealed massive hepatomegaly and a CT scan of the liver confirmed coarse liver lesions. Histology from a liver biopsy was consistent with a large cell (non-small cell) neuroendocrine carcinoma. A CT scan of the chest showed a large anterior mediastinal mass unrelated to the lung, suggesting that the anterior mediastinum was the primary origin of the tumour. The patient was planned to receive platinum/etoposide chemotherapy for a metastatic mediastinal large cell neuroendocrine carcinoma. Unfortunately, her health deteriorated, and she was unfit to undergo any further treatment. She was treated palliatively and died 2 months after the diagnosis.
Keyphrases
- single cell
- computed tomography
- cell therapy
- lymph node
- healthcare
- stem cells
- squamous cell carcinoma
- ultrasound guided
- dual energy
- risk assessment
- magnetic resonance imaging
- mental health
- early onset
- mesenchymal stem cells
- positron emission tomography
- case report
- bone marrow
- contrast enhanced
- spinal cord injury
- spinal cord
- combination therapy
- human health
- rectal cancer